Jun 02 (Tuesday)
YRI
YRI Video Podcasts are back: Consumers’ huge cash stash set to fuel V-shaped recovery.
Morning Briefing PDF
Daily Markets
Markets
U.S. stocks gain as signs of recovery offset protests, economic worries R
Stocks Start Week With Modest Gains W
‘Bankrupt in Just Two Weeks’—Individual Investors Get Burned by Collapse of Complex Securities W
Credit
Poor Countries Face a Debt Crisis ‘Unlike Anything We Have Seen’ N
US
U.S. manufacturing activity crawls off 11-year low R
Output Decline at Factories Eases, But Recovery Set to Be Slow W
Mortgage Sector Off to Worst Start Since 2013 Despite Fed Help B
Small Business Owners Grateful for Aid, but Worried About What Comes Next N
Global
China’s Barely Begun Economic Recovery Shows Signs of Stalling W
U.K. Economy Now Running at 85% Normal Capacity, Barclays Says B
US politics
Trump Pushes Governors to Get Tough on Violent Protesters W
Voting by Mail to Face Biggest Test Since Pandemic Started W
Record rise in unemployment casts a shadow over Trump’s re-election bid MW
Geopolitics & trade
A semiconductor ‘cold war’ is heating up between the U.S. and China MW
‘Lemon’ or not, Trump stuck with Phase 1 China trade deal for now R
WHO pushes to keep ties with ‘generous’ U.S. despite Trump’s exit move R
Congress must fix America’s unconstitutional trade laws
Russia Sets July 1 Vote on Constitutional Changes Allowing Putin to Extend His Rule W
Industries & companies
Casinos: Protests may derail an expected strong reopening for Las Vegas casinos C
Consumer: Nestlé Loses Fight With Impossible Foods Over Meatless Burger Branding W
FAANGs: Facebook Employees Stage Virtual Walkout to Protest Trump Posts N
Media: YouTube’s Chase for Streaming-TV Ad Dollars Faces Hurdles W
Corporate finance
Zynga to Buy Turkish Mobile-Game Studio Peak for $1.8 Billion W
Virus I
WHO says coronavirus isn’t losing potency: ‘This is still a killer virus’ C
Coronavirus May Be a Vascular Disease, Which Explains Everything
The Long-Term Health Impacts of Being Infected With the Coronavirus
Virus II
Does Hydroxychloroquine Work? Here’s What Science Says
Eli Lilly Begins Testing Covid-19 Drug Derived From Blood of Survivor W
A new batch of data for Gilead Sciences’ remdesivir points to efficacy but it’s no ‘silver bullet’ MW
Gilead’s Covid-19 Drug Remdesivir Modest Benefit in Large Trial B
Chicken Soup, Remdesivir and Deep Breaths: How Older Patients Survived Covid-19 W
Warnings Surface About New System to Disinfect N95 Masks W
